For Physicians

Our patented diagnostic blood test, EndomiR, is now available in fertility clinics across Canada.

Delayed Diagnosis

Endometriosis, a commonly overlooked condition that is plagued by diagnostic delays spanning 5 to 12 years (Patient Safety Network, 2020; Singh et al., 2020). Its nonspecific symptoms, comorbidity with other disorders, and normalization of symptoms all contribute in part to documented diagnostic delays.

Research shows that prolonged diagnostic delay correlates with increased symptom severity and increased healthcare costs (Surrey et al., 2020), emphasizing the urgent need for earlier diagnosis and improved treatment accessibility, alleviating the cost and frustrations for both physicians and patients alike.

infographic of areas of life impacted by endometriosis

Afynia’s screening panel delivers actionable data for physicians and patients in days not years, transforming the diagnostic journey.

Comparable to the diagnostic gold standard, laparoscopy, EndomiR offers rapid, accurate screening for endometriosis in those with chronic pelvic pain or infertility, ensuring timely intervention and enhancing the standard of care for women.

Screening Pathway
Referral to clinic

Referral to clinic

Initial screening

Initial screening

Blood drawn

Blood drawn

Ship to Afynia

Ship to Afynia

Results to doctor

Results to doctor

Treatment plan

Treatment plan

Our Goals
  • Earlier relief
  • Improved quality of life
  • Patient-physician clarity
  • Referrel support
Cost Effective Icon
Accurate Icon
Fast Icon
Reliable Icon
What Physicians Say
“The EndomiR Test is a Game Changer”

For the millions of people suffering from chronic pain, it can be a life saver to receive a diagnosis.

"

"This is the real deal. EndomiR is a revolutionary test that has transformed my practice and improved patient management. With this test, diagnostic physicians can now function fully by providing patients with objective data to support clinical diagnoses, eliminating theoretical assumptions."

Dr. John McNaught

Reproductive Endocrinologist & Infertility Specialist in Ontario, Canada

How Testing with EndomiR Works
StepsIcon

Obtain

blood sample

arrow
StepsIcon

RNA

extraction

arrow
StepsIcon

cDNA

synthesis

arrow
StepsIcon

miRNA profiling

by PCR

arrow
StepsIcon

Statistical

analysis

arrow
StepsIcon

Results

available

Afynia’s screening panel screens for the expression levels of circulating microRNAs (miRNAs) that are differentially expressed in women with endometriosis versus symptomatic controls. EndomiR accurately screens for endometriosis and delivers objective data for informed decision-making.

FAQ About EndomiR

To learn more about EndomiR, please email us at info@afynia.com or phone at 1-888-829-2462.

How has the science behind the test been validated?

The validity of results using Afynia's diagnostic marker panel results has been confirmed through multiple blinded prospective internal and external clinical validation studies ensuring the scientific reliability of our approach.

What are the clinical applications of EndomiR?

EndomiR is indicated for use in women with chronic pelvic pain, menstrual pain, and/or unexplained infertility. It is not indicated for use in women with or suspected reproductive cancers.

EndomiR provides a probability score for endometriosis with accuracy equivalent to the gold-standard diagnostic tool, laparoscopy.

How does shipment of blood samples to Afynia work?

Patient plasma samples collected in the clinic lab are stored frozen at -20°C, batched, and shipped by courier (FedEx) to the Afynia lab at 270 Longwood Road South, Hamilton, Ontario, Canada L8P 0A6.

Does Afynia accept samples from the US?

Yes. Afynia is able to accept and process samples from US-based physicians and clinics.

Become a partnered clinic
If you would like to distribute our blood test through your own clinic, register below.